Create a free OEM Magazine account to continue reading

Pharma Packaging’s Next Phase: Connectivity

Future-ready pharma packaging must integrate connectivity, automation, and material strategy into a single, coordinated approach rather than treating them as separate initiatives.

Screenshot 2026 02 25 At 9 09 47 Am
PMMI Business Intelligence: 2026 Trends and Challenges in Pharmaceutical Manufacturing

Pharmaceutical packaging is shifting toward digital connectivity with RFID, temperature monitoring, and scannable codes to improve traceability, prevent counterfeiting, and meet regulatory requirements. Current adoption includes 69% using temperature monitoring and 67% using QR codes, while RFID and wireless sensors are emerging as the next major wave.

  • Current adoption leaders: 69% of pharma manufacturers use temperature and humidity monitoring, and 67% deploy QR codes or scannable features
  • Emerging technologies: 27% plan to add RFID tags, 25% expect wireless packaging sensors, and 23% are exploring augmented reality
  • Key drivers: Serialization mandates, anti-counterfeiting requirements, and supply chain traceability demands are accelerating adoption
  • RFID advantages: Stores more data than printed codes, enables automated tracking, and provides item-level authentication for cold chain and high-value injectables
  • Industry momentum: RFID is transitioning from testing phase to mainstream requirement, with major retailers and brands mandating embedded tags in products

Pharmaceutical packaging is entering a more connected and compliance-driven era, where digital functionality is becoming as critical as barrier protection. New industry data show manufacturers accelerating adoption of temperature monitoring, scannable codes, and RFID—while simultaneously balancing sustainability mandates and tighter regulatory oversight.

Currently, monitoring and scannable features dominate packaging features. According to PMMI’s Trends and Challenges in Pharmaceutical Manufacturing report, 69% of respondents already utilize temperature and humidity monitoring and 67% use QR codes or other scannable features.

Other technology features like RFID (33%) and wireless sensors (13%) are looming, but not yet mainstream.

“RFID technology is emerging as a major requirement,” an OEM VP of Product Development said. “Major store brands are requiring RFID tags be embedded in products, and pharma is adopting this for inventory management. We’ve been asked to work on embedding RFID tags in shrink sleeves. We've been testing with film manufacturers who embed tags in each label. We haven't sold equipment for this yet, but expect it to become huge soon.” 

While monitoring tools such as temperature indicators and QR codes are now common in pharmaceutical packaging, the next wave of investment is shifting toward deeper connectivity. According to the report, 27% of CPGs plan to add RFID tags, 25% expect to incorporate wireless packaging sensors, and 23% are looking at augmented reality features.

The drivers are both regulatory and operational. Serialization mandates and anti-counterfeiting pressures are pushing manufacturers toward technologies that enable item-level traceability and authentication. Unlike traditional printed codes, RFID and near-field technologies can store more data and enable automated tracking throughout the supply chain. For manufacturers managing cold chain distribution or high-value injectables, that added visibility can help reduce disputes, verify the chain of custody, and support compliance documentation.

SOURCE: 2026 Trends and Challenges in Pharmaceutical Manufacturing

For more insights from PMMI’s Business Intelligence team, find reports, including Trends and Challenges in Pharmaceutical Manufacturing, Automation in Food and Beverage Equipment Sanitation, and Knowledge Transfer for Machine Operators: From Paper to Digital Intelligence at https://www.pmmi.org/business-intelligence.

Download the FREE report below.